Goal Directed Propofol Sedation With Magnesium Sulphate Versus Dexmedetomidine for ERCP Procedure

NCT02684019 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Lack of Drug Action

Interventions

DRUG: Dexmedetomidine
DRUG: Magnesium Sulphate

Sponsor

Theodor Bilharz Research Institute